A
Anthony Kim
Researcher at Boston University
Publications - 3
Citations - 1887
Anthony Kim is an academic researcher from Boston University. The author has contributed to research in topics: Magnetic resonance imaging & Perfusion. The author has an hindex of 3, co-authored 3 publications receiving 1689 citations.
Papers
More filters
Journal ArticleDOI
Unified huntington’s disease rating scale: Reliability and consistency
Karl Kieburtz,John B. Penney,Peter Corno,Neal G. Ranen,Ira Shoulson,Andrew Feigin,Davi Abwender,J. Timothy Greenarnyre,Donald S. Higgins,Frederick J. Marshall,Joshua L. Goldstein,Kimberly Steinberg,Charles Shih,Irene H. Richard,Charlyne Hickey,Carol Zimmerman,Constance Orme,Kathy Claude,David Oakes,Daniel S. Sax,Anthony Kim,Steven M. Hersch,Randi Jones,Alexander P. Auchus,David B. Olsen,Cheryl Bissey-Black,Allen Rubin,Rose Schwartz,Richard Dubinsky,William Mallonee,Carolyn Gray,Nan Godfrey,Greg Suter,Kathleen M. Shannon,Glenn T. Stebbins,Jean A. Jaglin,Karen Marder,Stuart Taylor,Elan D. Louis,Carol Moskowitz,Deborah Zeck Thorne,Naomi Zubin,Nancy S. Wexler,Michael R. Swenson,Jane S. Paulsen,Neal R. Swerdlow,Roger L. Albin,Christine Wernette,Francis O. Walker,Vicki Hunt +49 more
TL;DR: The limited longitudinal database indicates that the UHDRS may be useful for tracking changes in the clinical features of HD over time and there was an excellent degree of interrater reliability for the motor scores.
Journal ArticleDOI
Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography
Daniel S. Sax,Rachel A. Powsner,Anthony Kim,Shripad Tilak,Rita Bhatia,L. Adrienne Cupples,Richard H. Myers +6 more
TL;DR: In this article, the extent of cortical perfusion correlated with clinical assessments of functional capabilities as well as with the duration of disease, and no significant clinical correlations with sensory cortices.
Journal ArticleDOI
Lack of Hepatotoxicity with Naltrexone Treatment
TL;DR: Chronic administration of naltrexone in doses up to 300 mg/day for periods up to 36 months does not significantly change hepatic function, as measured by SGOT and SGPT levels.